Table 4.
Antimicrobial use in a university hospital in Anhui, China, 2010–2017
| Variables | 2010–2011 (N = 2166) | 2012–2013 (N = 3166) | 2014–2015 (N = 3307) | 2016–2017 (N = 3866) | Total (N = 12 505) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | |
| Patients receiving antimicrobial agent | 1161 | 53.60 | 1439 | 45.45 | 1336 | 40.40 | 1583 | 40.95 | 5519 | 44.13 |
| Purpose of antimicrobial use | ||||||||||
| Treatment | 505 | 43.50 | 964 | 66.99 | 890 | 66.62 | 1012 | 63.93 | 3371 | 61.08 |
| Prophylaxis | 522 | 44.96 | 126 | 8.76 | 301 | 22.53 | 420 | 26.53 | 1369 | 24.81 |
| Treatment and Prophylaxis | 134 | 11.54 | 349 | 24.25 | 145 | 10.85 | 151 | 9.54 | 779 | 14.11 |
| Therapy | ||||||||||
| Mono therapy | 761 | 65.55 | 1196 | 83.11 | 967 | 72.38 | 1145 | 72.33 | 4069 | 73.73 |
| Dual therapy | 370 | 31.87 | 185 | 12.86 | 337 | 25.22 | 379 | 23.94 | 1271 | 23.03 |
| Triple (or multi-drug) therapy | 30 | 2.58 | 58 | 4.03 | 32 | 2.40 | 59 | 3.73 | 179 | 3.24 |